BackSummary
Sanofi priced €2.3 billion of notes across three tranches for general corporate purposes, led by global coordinators.
Key takeaways
- Sanofi issued €2.3 billion in fixed-rate notes across three tranches due 2029, 2033, and 2037.
- Proceeds will be used for general corporate purposes, providing financial flexibility.
- The offering was led by Citigroup, HSBC, and J.P. Morgan as global coordinators.
- Notes are issued under Sanofi's Euro Medium Term Note programme.
- Interest rates range from 3.000% to 3.750% depending on maturity.